Cargando…

Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women

Objective To analyze the use of the measurement of uterine cervix length (MUCL) and the fetal fibronectin (fFN) rapid test as predictors of preterm delivery (PTD) in symptomatic pregnant women assisted at the Santa Casa de Misericórdia de Sobral Maternity Hospital. Methods This was a prospective and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinheiro Filho, Tadeu Rodriguez de Carvalho, Pessoa, Vanessa Rocha, Lima, Thaisa de Sousa, Castro, Marcela Melo de, Linhares, José Juvenal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316900/
https://www.ncbi.nlm.nih.gov/pubmed/30231289
http://dx.doi.org/10.1055/s-0038-1667185
_version_ 1785067805943529472
author Pinheiro Filho, Tadeu Rodriguez de Carvalho
Pessoa, Vanessa Rocha
Lima, Thaisa de Sousa
Castro, Marcela Melo de
Linhares, José Juvenal
author_facet Pinheiro Filho, Tadeu Rodriguez de Carvalho
Pessoa, Vanessa Rocha
Lima, Thaisa de Sousa
Castro, Marcela Melo de
Linhares, José Juvenal
author_sort Pinheiro Filho, Tadeu Rodriguez de Carvalho
collection PubMed
description Objective To analyze the use of the measurement of uterine cervix length (MUCL) and the fetal fibronectin (fFN) rapid test as predictors of preterm delivery (PTD) in symptomatic pregnant women assisted at the Santa Casa de Misericórdia de Sobral Maternity Hospital. Methods This was a prospective and analytic study involving 53 parturients assisted between September of 2015 and July of 2016; the participants were between 24 and 34 weeks of gestational age (GA) and presented complaints related to preterm labor (PTL) prodromes. Vaginal secretion was collected for fFN testing, and the MUCL was obtained via transvaginal ultrasonography. Results A total of 58.49% of the subjects showed MUCL < 25 mm, and 41.51% were positive in the fFN rapid test. A total of 48 patients were followed-up until their delivery date, and 54.17% resulted in PTL. The relative risk (RR) for PTD in patients with MUCL < 25 mm was 1.83 (p = 0.09, 0.99–3.36, 95% confidence interval [CI]), with a mean time before delivery of 2.98 weeks. Based on fFN positive results, the RR was 3.50 (p = 0.002, 1.39–8.79, 95%CI) and the mean time until delivery was 1.94 weeks. The RR was 2.70 (p = 0.002, 1.08–6.72, 95%CI) when both tests were used. The RR of PTD within 48 hours, and 7 and 14 days were, respectively, 1.30 (p = 0.11, 95% CI 1.02–1.67), 1.43 (p = 0.12, 95% CI % 0.99–2.06), and 2.03 (p = 0.008, 95% CI 1.26–3.27), when based on the MUCL, and 1.75 (p = 0.0006, 95% CI 1.20–2.53), 2.88 (p = 0.0001, 95% CI, 1.57–5.31), and 3.57 (p = 0.0002, 95% CI 1.63–7.81) when based on positive fFN results. The RR at 48 hours and 7 and 14 days considering both tests was 1.74 (p = 0.0001, 95% CI 1.14–2.64), 2.22 (p = 0.0001, 95% CI 1.22–4.04), and 2.76 (p = 0.0002, 95% CI 1.27–5.96), respectively. Conclusion In symptomatic pregnant women, we concluded that the MUCL < 25 mm associated with positive fFN rapid test indicate increased the risk for PTD. Further studies with larger sample sizes could contribute in supporting the results presented in the current study.
format Online
Article
Text
id pubmed-10316900
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Thieme Revinter Publicações Ltda
record_format MEDLINE/PubMed
spelling pubmed-103169002023-07-27 Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women Pinheiro Filho, Tadeu Rodriguez de Carvalho Pessoa, Vanessa Rocha Lima, Thaisa de Sousa Castro, Marcela Melo de Linhares, José Juvenal Rev Bras Ginecol Obstet Objective To analyze the use of the measurement of uterine cervix length (MUCL) and the fetal fibronectin (fFN) rapid test as predictors of preterm delivery (PTD) in symptomatic pregnant women assisted at the Santa Casa de Misericórdia de Sobral Maternity Hospital. Methods This was a prospective and analytic study involving 53 parturients assisted between September of 2015 and July of 2016; the participants were between 24 and 34 weeks of gestational age (GA) and presented complaints related to preterm labor (PTL) prodromes. Vaginal secretion was collected for fFN testing, and the MUCL was obtained via transvaginal ultrasonography. Results A total of 58.49% of the subjects showed MUCL < 25 mm, and 41.51% were positive in the fFN rapid test. A total of 48 patients were followed-up until their delivery date, and 54.17% resulted in PTL. The relative risk (RR) for PTD in patients with MUCL < 25 mm was 1.83 (p = 0.09, 0.99–3.36, 95% confidence interval [CI]), with a mean time before delivery of 2.98 weeks. Based on fFN positive results, the RR was 3.50 (p = 0.002, 1.39–8.79, 95%CI) and the mean time until delivery was 1.94 weeks. The RR was 2.70 (p = 0.002, 1.08–6.72, 95%CI) when both tests were used. The RR of PTD within 48 hours, and 7 and 14 days were, respectively, 1.30 (p = 0.11, 95% CI 1.02–1.67), 1.43 (p = 0.12, 95% CI % 0.99–2.06), and 2.03 (p = 0.008, 95% CI 1.26–3.27), when based on the MUCL, and 1.75 (p = 0.0006, 95% CI 1.20–2.53), 2.88 (p = 0.0001, 95% CI, 1.57–5.31), and 3.57 (p = 0.0002, 95% CI 1.63–7.81) when based on positive fFN results. The RR at 48 hours and 7 and 14 days considering both tests was 1.74 (p = 0.0001, 95% CI 1.14–2.64), 2.22 (p = 0.0001, 95% CI 1.22–4.04), and 2.76 (p = 0.0002, 95% CI 1.27–5.96), respectively. Conclusion In symptomatic pregnant women, we concluded that the MUCL < 25 mm associated with positive fFN rapid test indicate increased the risk for PTD. Further studies with larger sample sizes could contribute in supporting the results presented in the current study. Thieme Revinter Publicações Ltda 2018-09 /pmc/articles/PMC10316900/ /pubmed/30231289 http://dx.doi.org/10.1055/s-0038-1667185 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pinheiro Filho, Tadeu Rodriguez de Carvalho
Pessoa, Vanessa Rocha
Lima, Thaisa de Sousa
Castro, Marcela Melo de
Linhares, José Juvenal
Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title_full Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title_fullStr Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title_full_unstemmed Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title_short Risk Assessment for Preterm Delivery using the Fetal Fibronectin Test Associated with the Measurement of Uterine Cervix Length in Symptomatic Pregnant Women
title_sort risk assessment for preterm delivery using the fetal fibronectin test associated with the measurement of uterine cervix length in symptomatic pregnant women
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316900/
https://www.ncbi.nlm.nih.gov/pubmed/30231289
http://dx.doi.org/10.1055/s-0038-1667185
work_keys_str_mv AT pinheirofilhotadeurodriguezdecarvalho riskassessmentforpretermdeliveryusingthefetalfibronectintestassociatedwiththemeasurementofuterinecervixlengthinsymptomaticpregnantwomen
AT pessoavanessarocha riskassessmentforpretermdeliveryusingthefetalfibronectintestassociatedwiththemeasurementofuterinecervixlengthinsymptomaticpregnantwomen
AT limathaisadesousa riskassessmentforpretermdeliveryusingthefetalfibronectintestassociatedwiththemeasurementofuterinecervixlengthinsymptomaticpregnantwomen
AT castromarcelamelode riskassessmentforpretermdeliveryusingthefetalfibronectintestassociatedwiththemeasurementofuterinecervixlengthinsymptomaticpregnantwomen
AT linharesjosejuvenal riskassessmentforpretermdeliveryusingthefetalfibronectintestassociatedwiththemeasurementofuterinecervixlengthinsymptomaticpregnantwomen